FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Appco Pharma Prazosin Hydrochloride Capsules Recall

Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for…

Appco Pharma LLC · Piscataway, NJ

Risk level
Class II
Reported by FDA
Apr 8, 2026
Recall ID
D-0420-2026
Check your lot numberHow we source this data

Summary

Appco Pharma recalled Prazosin Hydrochloride Capsules starting Mar 27, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0420-2026 on Apr 8, 2026. Reason: cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. Status: Ongoing.

Why it was recalled

cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

Product description

Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11.

Lot numbers, UPCs & expiration codes

Lot:2404153UC, Exp.: 2026/MAR; 2404154UC, Exp.:2026/MAR; 2502055UC, Exp.: 2027/JAN; 2505173UC, Exp.: 2027/MAY; 2505175UC, Exp.: 2027/MAY.

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0420-2026
Classification
Class II
Status
Ongoing
Recall initiated
Mar 27, 2026
FDA report date
Apr 8, 2026
Quantity
58,896 bottles- 100's count
Recall type
Voluntary: Firm initiated
Recalling firm
Appco Pharma LLC

Original FDA data

Every field from FDA enforcement report D-0420-2026, exactly as published.

Show all FDA fields
City
Piscataway
State
NJ
Status
Ongoing
Country
United States
Event ID
98658
Address
262 Old New Brunswick Rd Ste N
Code information
Lot:2404153UC, Exp.: 2026/MAR; 2404154UC, Exp.:2026/MAR; 2502055UC, Exp.: 2027/JAN; 2505173UC, Exp.: 2027/MAY; 2505175UC, Exp.: 2027/MAY.
Postal code
08854-3888
Report date
Apr 8, 2026
Product type
Drugs
Recall number
D-0420-2026
Classification
Class II
Recalling firm
Appco Pharma LLC
Product quantity
58,896 bottles- 100's count
Reason for recall
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11.
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Mar 27, 2026
Initial firm notification
E-Mail
Center classification date
Mar 31, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0420-2026, published Apr 8, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls